Suzetrigine in Equestrian Sports: Optimized Extraction and LC-HRMS Detection Strategies
Rationale: Suzetrigine, a recently approved Na V1.8 sodium channel blocker, shows strong potential in the treatment of neurological, psychiatric, and pain-related conditions. Its peripheral selectivity enables effective pain management while avoiding
Authors
- Shino Ann Koshy
- Moses Philip (ORCID: https://orcid.org/0000-0001-8696-3702)
- Tajudheen K. Karatt (ORCID: https://orcid.org/0000-0002-4344-2517)
- Muhammed Ajeebsanu
- Abdul Khader Karakka Kal (ORCID: https://orcid.org/0000-0002-6928-5513)
- Michael Benedict Subhahar (ORCID: https://orcid.org/0000-0003-2712-0128)
Institutions
- Central Veterinary Research Laboratory (AE)
Publication Details
- Published
- 2025-08-20
- DOI
- https://doi.org/10.22541/au.175571285.57328891/v1
- Primary Topic
- Pharmacological Effects and Assays
- Type
- article
- Field-Weighted Citation Impact
- 0.00